Chapter 7 Grafts, growth factors and grafts that make growth factorsCynthia Wetmore, Christiana Ayer-LeLievre, Ted Ebendal et al.|Progress in brain research|1990Cited by 34
A Phase 1 Study of CFT7455, a Novel Degrader of IKZF1/3, in Multiple Myeloma and Non-Hodgkin LymphomaJesús G. Berdeja, Sagar Lonial, Paul G. Richardson et al.|Blood|2021Cited by 22
Abstract CT186: Pharmacokinetic (PK) profile of a novel IKZF1/3 degrader, CFT7455, enables significant potency advantage over other IKZF1/3 degraders in models of multiple myeloma (MM) and the results of the initial treatment cohort from a first-in-human (FIH) phase 1/2 study of CFT7455 in MMSagar Lonial, Jesus Bardeja, Shambavi Richard et al.|Cancer Research|2022Cited by 11
Electrophysiologic effects of ethanol in human brain xenografts in oculo: antagonism by Ro15-4513.Michael R. Palmer, A.-Ch. Granholm, M. Bygdeman et al.|Journal of Pharmacology and Experimental Therapeutics|1990Cited by 4